Berberine (BBR) has a neuroprotective effect against ischemic stroke, but its specific protective mechanism has not been clearly elaborated. This study explored the effect of BBR on the canopy FGF signaling regulator 2 (CNPY2) signaling pathway in the ischemic penumbra of rats. The model of cerebral ischemia-reperfusion injury (CIRI) was established by the thread embolization method, and BBR was gastrically perfused for 48 h or 24 h before operation and 6 h after operation. The rats were randomly divided into four groups: the Sham group, BBR group, CIRI group, and CIRI + BBR group. After 2 h of ischemia, followed by 24 h of reperfusion, we confirmed the neurologic dysfunction and apoptosis induced by CIRI in rats (p < 0.05). In the ischemic penumbra, the expression levels of CNPY2-regulated endoplasmic reticulum stress-induced apoptosis proteins (CNPY2, glucose-regulated protein 78 (GRP78), double-stranded RNA-activated protein kinase-like ER kinase (PERK), C/EBP homologous protein (CHOP), and Caspase-3) were significantly increased, but these levels were decreased after BBR treatment (p < 0.05). To further verify the inhibitory effect of BBR on CIRI-induced neuronal apoptosis, we added an endoplasmic reticulum-specific agonist and a PERK inhibitor to the treatment. BBR was shown to significantly inhibit the expression of apoptotic proteins induced by endoplasmic reticulum stress agonist, while the PERK inhibitor partially reversed the ability of BBR to inhibit apoptotic protein (p < 0.05). These results confirm that berberine may inhibit CIRI-induced neuronal apoptosis by downregulating the CNPY2 signaling pathway, thereby exerting a neuroprotective effect.
18 October 2019 in Journal of Cellular and Molecular Medicine
Dexmedetomidine (Dex) has been proven to exert protective effects on multiple organs in response to ischaemia‐reperfusion injury, but the specific mechanism by which this occurs has not been fully elucidated. The purpose of this study was to investigate whether Dex attenuates spinal cord ischaemia‐reperfusion injury (SCIRI) by inhibiting endoplasmic reticulum stress (ERS). Our team established a model of SCIRI and utilized the endoplasmic reticulum agonist thapsigargin. Dex (25 g/kg) was intraperitoneally injected 30 minutes before spinal cord ischaemia. After 45 minutes of ischaemia, the spinal cord was reperfused for 24 hours. To evaluate the neuroprotective effect of Dex on SCIRI, neurological function scores were assessed in rats and apoptosis of spinal cord cells was determined by TUNEL staining. To determine whether the endoplasmic reticulum apoptosis pathway CNPY2‐PERK was involved in the neuroprotective mechanism of Dex, the expression levels of related proteins (CNPY2, GRP78, PERK, CHOP, caspase‐12, caspase‐9 and caspase‐3) were detected by western blot analysis and RT‐PCR. We observed that Dex significantly increased the neurological function scores after SCIRI and decreased apoptosis of spinal cord cells. The expression of ERS‐related apoptosis proteins was significantly increased by SCIRI but was significantly decreased in response to Dex administration. Taken together, the results of this study indicate that Dex may attenuate SCIRI by inhibiting the CNPY2‐ERS apoptotic pathway.
Myocardial bridges are congenital anatomical abnormalities in which myocardium covers a segment of coronary arteries, leading to stenocardia, myocardial ischemia, and sudden cardiac death in severe cases. However, automatic diagnosis of myocardial bridge presents significant challenges. A novel framework of myocardial bridge detection with x-ray angiography sequence is proposed, which can realize automatic detection of vessel stenosis and myocardial bridge. Firstly, we employ a novel neural network model for coronary vessel segmentation, which consists of both CNNs and transformer structures to effectively extract both local and global information of the vessels. Secondly, we describe the vessel segment information, establish the vessel tree in the image, and fuse the vessel tree information between sequences. Finally, based on vessel stenosis detection, we realize automatic detection of the myocardial bridge by querying the blood vessels between the image sequence information. In experiment, we evaluate the segmentation results using two metrics, Dice and ASD, and achieve scores of 0.917 and 1.39, respectively. In the stenosis detection, we achieve an average accuracy rate of 92.7% in stenosis detection among 262 stenoses. In multi-frame image processing, vessels in different frames can be well-matched, and the accuracy of myocardial bridge detection achieves 75%. Our experimental results demonstrate that the algorithm can automatically detect stenosis and myocardial bridge, providing a new idea for subsequent automatic diagnosis of coronary vessels.
Sedation is an essential component of the anesthesia process. Inadequate sedation during anesthesia increases the risk of patient discomfort, intraoperative awareness, and psychological trauma. Conventional electroencephalography (EEG) based depth of anesthesia monitoring is often impractical in out-of-hospital settings due to equipment limitations and signal artifacts. Alternative non-EEG-based approaches are therefore required. In this study, we developed a machine learning model to detect inadequate sedation using 27 feature parameters, including demographics, vital signs, and heart rate variability metrics, from the open-access VitalDB database. Patient states were defined as inadequate sedation when the bispectral index (BIS) > 60. We systematically evaluated four temporal windows and four algorithms, and assessed model interpretability using Shapley Additive Explanations (SHAP). The Light Gradient Boosting Machine (LGBM) achieved the best performance, with an area under the receiver operating characteristic curve (AUC) of 0.825 and an accuracy (ACC) of 0.741 using a 2 s time window. Extending the time window to 20 s improved both metrics by approximately 0.012. Feature selection identified 12 key parameters that maintained comparable accuracy, confirming robustness with reduced complexity. These findings demonstrate the feasibility of using non-EEG-based physiological data for real-time detection of inadequate sedation. The developed model is interpretable, resource-efficient, scalable, and shows strong potential for integration into portable monitoring systems in prehospital, emergency, and low-resource surgical settings.
16 December 2025 in Journal of Stroke and Cerebrovascular Diseases
With global population aging, the incidence of ischemic stroke is rising annually. However, its underlying mechanisms and effective clinical preventive and therapeutic measures remain elusive. This study investigated inflammatory mechanisms and therapeutic targets using a rat cerebral ischemia-reperfusion injury (CIRI) model, focusing on endoplasmic reticulum stress (ERS)-mediated inflammation. A rat CIRI model was established. Neurological assessments were performed 24 h post-modeling. Histopathological analysis evaluated inflammatory cytokines (IL-1β, TNF-α) and NF-κB p65 nuclear translocation in the ischemic penumbra. Molecular profiling assessed activation of endoplasmic reticulum stress (ERS) markers (GRP78, p-PERK, p-eIF2α) and the ERS-associated transcription factor Glutamine-rich protein 1 (QRICH1). Pharmacological induction of ERS and treatment with berberine (BBR) were employed, with mechanistic studies including PERK inhibition. Neurological assessments revealed significant CIRI-induced neural deficits. Histopathology demonstrated upregulated IL-1β/TNF-α and NF-κB p65 nuclear translocation. Molecular profiling identified activation of ERS markers (GRP78, p-PERK, p-eIF2α) and a time-dependent elevation of QRICH1 post-CIRI. Pharmacological ERS induction confirmed QRICH1/PERK/NF-κB pathway activation. BBR administration significantly attenuated IL-1β/TNF-α levels, suppressed IκB-α degradation, and inhibited NF-κB nuclear translocation. Mechanistically, BBR downregulated QRICH1 upregulation and suppressed agonist-induced ERS-inflammatory cascades; these therapeutic effects were partially reversed by PERK inhibitor. These findings propose modulation of the QRICH1-ERS pathway as a promising therapeutic target for CIRI management, with BBR conferring protection by partially suppressing this axis.